This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...
The new online Learning Center with new content can still be found under the “Training” folder on ...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...